Mental disorders are no predictors to determine the duration of cannabis-based treatment for chronic pain

Bibliographic Data

ID15522503
AuthorsCaroline Rometsch (0000-0002-3172-0823, University of Florence, corresponding author), S Ott (0000-0001-5925-314X, University of Tübingen), Teresa Festl‐Wietek (0000-0003-1450-1757, University of Tübingen), Teresa Festl-Wietek, Anna-Maria Jurjut (University of Tübingen), Barbara Schlisio (0000-0001-6492-4585, University Children's Hospital Tübingen), Stephan Zipfel (0000-0003-1659-4440, University of Tübingen), Andreas Stengel (0000-0003-3294-4340, Freie Universität Berlin), Anne Herrmann‐werner (0000-0003-2413-7047, University of Tübingen), Anne Herrmann-Werner
Year2023
Volume13
Pages1033020-1033020
Publication date2023-01-06
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2022.1033020
PMID36684012
OpenAlexW4313649877
LanguageEN
References cited56

We found no evidence indicating that the benefits of short-term vs. long-term cannabis-based treatment can be predicted by mental comorbidities or psychosocial factors. However, because CBM may be included in approaches to treat CP, questions about the ideal duration of such treatment remain to be answered

Anxiety · Biopsychosocial model · Cannabis · Chronic pain · DASS · Depression (economics · Mental health · Psychiatry · Psychosocial · Cannabis and Cannabinoid Research · Clinical Psychology · Medicine · Musculoskeletal pain and rehabilitation · Pain Mechanisms and Treatments

Tools

Open DOIOpen Access